Expression of the retinoic acid-metabolizing enzyme CYP26A1 limits programmed cell death

Molecular Pharmacology

Volumn 67, Issue 5, 2005, Pages 1808-1817

  Osanai, Makoto ^a   Petkovich, Martin ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; CYTOCHROME P450; CYTOCHROME P450 26A1; DEATH RECEPTOR; KETOCONAZOLE; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; TAMIBAROTENE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER; CARCINOGENESIS; CELL PROTECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME INACTIVATION; ENZYME SPECIFICITY; GENE OVEREXPRESSION; HELA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; RETINOL DEFICIENCY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; VITAMIN METABOLISM;

APOPTOSIS; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; TRETINOIN;

EID: 17844366276     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.005769     Document Type: Article

References (39)

1. Abu-Abed S, Dolle P, Metzger D, Beckett B, Chambon P, and Petkovich M (2001) The retinoic acid-metabolizing enzyme, CYP26A1, is essential for normal hindbrain patterning, vertebral identity and development of posterior structures. Genes Dev 15:226-240.
2. Chithalen JV, Luu L, Petkovich M, and Jones G (2002) HPLC-MS/MS analysis of the products generated from all-trans-retinoic acid using recombinant human CYP26A. J Lipid Res 43:1133-1142.
3. Daly AK, Rees JL, and Redfern CP (1989) Nuclear retinoic-acid-binding proteins and receptors in retinoic-acid-responsive cell lines. Exp Cell Biol 57:339-345.
4. de Thé H (1996) Altered retinoic acid receptor. FASEB J 10:955-960.
5. Durston AJ, Timmermans JP, Hage WJ, Hendriks HF, de Vries NJ, Heideveld M, and Nieuwkoop PD (1989) Retinoic acid causes an anteroposterior transformation in the developing central nervous system. Nature (Lond) 340:140-144.
6. Evan GI and Vousden KH (2001) Proliferation, cell cycle and apoptosis in cancer. Nature (Lond) 411:342-348.
7. Fenaux P and Chomienne C (1996) Biology and treatment of acute promyelocytic leukemia. Curr Opin Oncol 8:3-12.
8. Fenaux P and Degos L (1997) Differentiation therapy for acute promyelocytic anemia. N Engl J Med 337:1076-1077.
9. Ferri KF and Kroemer G (2001) Organelle-specific initiation of cell death pathways. Nat Cell Biol 3:E255-E263.
10. Fisher DE (1994) Apoptosis in cancer therapy: crossing the threshold. Cell 78:539-542.
11. Geisen C, Denk C, Gremm B, Baust C, Karger A, Bollag W, and Schwarz E (1997) High-level expression of the retinoic acid receptor beta in normal cells of the uterine cervix is regulated by the retinoic acid receptor alpha and is abnormally down-regulated in cervical carcinoma cells. Cancer Res 57:1460-1467.
12. Gozani O, Boyce M, Yoo L, Karuman P, and Yuan J (2002) Life and death in paradise. Nat Cell Biol 4:E159-E162.
13. Green DR and Evan GI (2002) A matter of life and death. Cancer Cell 1:19-30.
14. Gross A, McDonnell JM, and Korsmeyer SJ (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13:1899-1911.
15. Hansen LA, Sigman CC, Andreola F, Ross SA, Kelloff GJ, and De Luca LM (2000) Retinoids in chemoprevention and differentiation therapy. Carcinogenesis 21:1271-1279.
16. Hong WK and Sporn MB (1997) Recent advances in chemoprevention of cancer. Science (Wash DC) 278:1073-1077.
17. Hsu SL, Chen MC, Chou YH, Hwang GY, and Yin SC (1999) Induction of p21 (CIP1/Waf1) and activation of p34 (cdc2) involved in retinoic acid-induced apoptosis in human hepatoma Hep3B cells. Exp Cell Res 248:87-96.
18. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, and Wang ZY (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567-572.
19. Kastner P, Mark M, and Chambon P (1995) Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 83:859-869.
20. Klaassen I, Brakenhoff RH, Smeets SJ, Snow GB, and Braakhuis BJ (2001) Metabolism and growth inhibition of four retinoids in head and neck squamous normal and malignant cells. Br J Cancer 85:630-635.
21. Lotan R (1996) Retinoids in cancer chemoprevention. FASEB J 10:1031-1039.
22. Luu L, Ramshaw H, Tahayato A, Stuart A, Jones G, White J, and Petkovich M (2001) Regulation of retinoic acid metabolism. Adv Enzyme Regul 41:159-175.
23. MacLean G, Abu-Abed S, Dolle P, Tahayato A, Chambon P, and Petkovich M (2001) Cloning of a novel retinoic-acid metabolizing cytochrome P450, Cyp26B1 and comparative expression analysis with Cyp26A1 during early murine development. Mech Dev 107:195-201.
24. Mahler C, Verhelst J, and Denis L (1993) Ketoconazole and liarozole in the treatment of advanced prostatic cancer. Cancer 71 (3 Suppl):1068-1073.
25. Mangelsdorf DJ and Evans RM (1995) The RXR heterodimers and orphan receptors. Cell 83:841-850.
26. Means A and Gudas LJ (1995) The roles of retinoids in vertebrate development. Annu Rev Biochem 64:210-233.
27. Muindi JR, Frankel SR, Huselton C, DeGrazia F, Garland WA, Young CW, and Warrell RP (1992) Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res 52:2138-2142.
28. Osanai M, Ogawa K, and Lee GH (1997) Phenobarbital causes apoptosis in conditionally immortalized mouse hepatocytes depending on deregulated c-myc expression: characterization of an unexpected effect. Cancer Res 57:2896-2903.
29. Ozpolat B, Mehta K, Tari AM, and Lopez-Berestein G (2002) All-trans-retinoic acid-induced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemia. Am J Hematol 70:39-47.
30. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, and Peter ME (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO (Eur Mol Biol Organ) J 17:1675-1687.
31. Schneider SM, Offterdinger M, Huber H, and Grunt TW (2000) Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid response in SK-BR-3 and T47D human breast cancer cells. Cancer Res 60:5479-5487.
32. Tahayato A, Dolle P, and Petkovich M (2003) Cyp26C1 encodes a novel retinoic acid-metabolizing enzyme expressed in the hindbrain, inner ear, first brachial arch and tooth buds during murine development. Gene Expr Patterns 3:449-454.
33. Taimi M, Helvig C, Wisniewski J, Ramshaw H, White J, Amada M, Korczak B, and Petkovich M (2004) A novel cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid. J Biol Chem 279:77-785.
34. Van Heusden J, Wouters W, Ramaekers FC, Krekels MD, Dillen L, Borgers M, Smets G (1998) The antiproliferative activity of all-trans-retinoic acid catabolites and isomers is differentially modulated by liarozole-fumarate in MCF-7 human breast cancer cells. Br J Cancer 77:1229-1235.
35. Wang YJ, Jeng JH, Chen RJ, Tseng H, Chen LC, Liang YC, Lin CH, Chen CH, Chu JS, Ho WL, and Ho YS (2002) Ketoconazole potentiates the antitumor effects of nocodazole: in vivo therapy for human tumor xenografts in nude mice. Mol Carcinog 34:199-210.
36. White E (1996) Life, death and the pursuit of apoptosis. Genes Dev 10:1-15.
37. White JA, Beckett-Jones B, Guo YD, Dilworth FJ, Bonasoro J, Jones G, and Petkovich M (1997) cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450. J Biol Chem 272:18538-18541.
38. Wolbach SB and Howe PR (1925) Tissue changes following deprivation of fat-soluble A vitamin. J Exp Med 42:753-777.
39. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, and Wang X (1997) 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science (Wash DC) 275:1129-1132.